High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Keyphrases

Immunology and Microbiology

Medicine and Dentistry